Boudriau S, Harvey C, Massicotte J, et al. Randomized Comparative bioavailability of a novel three-dimensional printed fast-melt formulation of levetiracetam following the administration of a single 1000-mg dose to healthy human volunteers under fasting and fed conditions. Drugs R D. 2016;16(2):229–238.

Channer K, Virjee JP. The effect of size and shape of tablets on their esophageal transit. J Clin Pharmacol. 1986;26:141–146.

Data on file. Aprecia Pharmaceuticals, LLC.

40% of American adults report experiencing difficulty swallowing pills [press release]. New York, NY: PR Newswire; January 15, 2004.

Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient’s perspective.

Ther Clin Risk Manag. 2008;4(1):269–286.

Liu F, Ranmal S, Batchelor HK, et al. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs. 2014;74(16):1871–1889.

Lyseng-Williamson KA. Spotlight on levetiracetam in epilepsy. CNS Drugs. 2011;25(10):901–905.

National Institute for Health and Care Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. 2015;137:1–117.

OTC Company News. Hermes highlights need for better formats.
Published July 2014. Accessed July 10, 2016.

Robbins J, Langmore S, Hind JA, Erlichman M. Dysphagia research in the 21st century and beyond: proceedings from Dysphagia Experts Meeting, August 21, 2001. J Rehabil Res Dev. 2002;39(4):543–548.

SPRITAM Medication Guide. Aprecia Pharmaceuticals, LLC.

SPRITAM Full Prescribing Information. Aprecia Pharmaceuticals, LLC.

Tablets and capsules that stick in the oesophagus. Drug Ther Bull. 1981;19(9):33–34.

US Food and Drug Administration. Size, shape, and other physical attributes of generic tablets and capsules. Washington, DC: US Department of Health and Human Services; 2015.